California start-up Bionaut Labs will conduct its first clinical trials on sending miniature robots deep inside the human skull to treat brain disorders
The tiny injectable robots can be guided through the brain using magnets.
Micro-robot technology "that used to be science fantasy in the 1950s and 1960s" is now "scientific fact," according to Michael Shpigelmacher, Bionaut Labs' founder and CEO.
Working with Germany's famed Max Planck research institutes, Bionaut Labs chose magnetic energy over optical or ultrasonic means to propel the robots because it is non-harmful to the human body.
Magnetic coils implanted outside the patient's skull are connected to a computer that can remotely and delicately navigate the micro-robot into the damaged area of the brain before withdrawing it the same way.
Unlike an MRI, the entire system is portable and utilizes 10 to 100 times less electricity.
The robot, which is a metal cylinder just a few millimeters long and shaped like a small bullet, follows a pre-programmed trajectory through a gel-filled container that mimics the density of the human brain in a simulation observed by AFP.
When the robot gets close enough to a pouch filled with blue liquid, it accelerates like a rocket and pierces the sack with its pointed end, allowing liquid to gush out.
When clinical trials begin in two years, the inventors want to use the robot to penetrate fluid-filled cysts in the brain.
The method could be used to cure Dandy-Walker Syndrome, a rare brain abnormality that affects youngsters if it is successful.
Cysts the size of a golf ball can form in congenital illness sufferers, swelling and increased pressure on the brain, initiating a slew of serious neurological problems.
Bionaut Labs has already tested its robots on large animals like lambs and pigs, and according to Shpigelmacher, "the evidence suggests that the technology is safe for us."
If approved, the robots could provide significant benefits over currently available therapies for brain illnesses.
Last year, the US Food and Drug Administration (FDA) awarded Bionaut Labs clearance to begin clinical studies for Dandy-Walker Syndrome and malignant gliomas, which are cancerous brain tumors that are frequently considered inoperable.
The micro-robots will be used to inject anti-cancer medications directly into brain tumors in a "surgical strike" in cancerous brain tumors.


China Buys 1 Million Tons of U.S. Soybeans Ahead of Xi Visit
The government is ‘doubling down’ on its social media ban. But bigger penalties for platforms aren’t enough
German Inflation Accelerates to 2.9% in August
Can Europe shake its Russia links for good?
Nvidia-Groq AI Chip Deal Faces U.S. Antitrust Probe
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Trump Administration Releases New UFO Files and Apollo Mission Records
Asian Stocks Slide as Oil Surge Fuels Rate Hike Fears
Gold Prices Steady as Hot PPI Boosts Fed Rate Hike Bets
Novartis Shares Plunge After Muscle Drug Fails Phase III Trial
Samsung, Qualcomm 2nm Chip Deal Delayed Over Pricing
Gold Prices Steady Ahead of U.S. Inflation Data and Fed Decision
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028
Hyundai Delays In-House ADAS, Turns to Nvidia
Tabletop particle accelerator could transform medicine and materials science 



